CHEBI:51013 - β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer ChEBI ID CHEBI:51013 ChEBI ASCII Name beta-D-GalNAc-(1->4)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer Definition A sialotriaosylceramide consisting of the tetrasaccharide β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc attached to the primary hydroxy function of ceramide. Stars This entity has been manually annotated by the ChEBI Team. Secondary ChEBI IDs CHEBI:12555, CHEBI:71582, CHEBI:12556, CHEBI:7115, CHEBI:21146 Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C50H86N3O26R Net Charge 0 Average Mass (excl. R groups) 1145.22230 Monoisotopic Mass (excl. R groups) 1144.54995 SMILES [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@@H]1[C@@H](O)[C@@H](O[C@H](CO)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](OC[C@H](NC([*])=O)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@@H]1CO)C(O)=O)[C@H](O)[C@H](O)CO Metabolite of Species Details Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed Roles Classification Biological Role(s): mouse metabolite Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus). View more via ChEBI Ontology ChEBI Ontology Outgoing β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:51013) has role mouse metabolite (CHEBI:75771) β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:51013) is a N-acetyl-β-D-galactosaminyl-(1→4)-[α-N-acetylneuraminyl-(2→3)]-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1)-ceramide (CHEBI:79217) β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:51013) is a sialotriaosylceramide (CHEBI:36541) β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:51013) is conjugate acid of β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(1−) (CHEBI:71502) Incoming N-acetyl-β-D-galactosaminyl-(1→4)-α-N-acetylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-N-acylsphingosine (CHEBI:21509) is a β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:51013) β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer(1−) (CHEBI:71502) is conjugate base of β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer (CHEBI:51013) IUPAC Name (2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 2-acetamido-2-deoxy-β-D-galactopyranosyl-(1→4)-[5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)]-β-D-galactopyranosyl-(1→4)-β-D-glucopyranoside Synonyms Sources (Gal)1 (GalNAc)1 (Glc)1 (Neu5Ac)1 (Cer)1 KEGG GLYCAN β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer CBN ganglioside GM2 ChEBI GM2 KEGG COMPOUND monosialoganglioside GM2 ChEBI N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-1,4-beta-D-glucosyl-N-acylsphingosine KEGG COMPOUND N-Acetyl-D-galactosaminyl-(N-acetylneuraminyl)-D-galactosyl-D-glucosylceramide KEGG COMPOUND Tay-Sachs ganglioside KEGG COMPOUND Manual Xrefs Databases C04884 KEGG COMPOUND G00109 KEGG GLYCAN WO0123431 Patent View more database links Citations Types Sources 1371229 PubMed citation Europe PMC 15546874 PubMed citation Europe PMC 18207611 PubMed citation Europe PMC 19130519 PubMed citation Europe PMC 2457654 PubMed citation Europe PMC 2564593 PubMed citation Europe PMC 25867522 PubMed citation Europe PMC 26050638 PubMed citation Europe PMC 28416698 PubMed citation Europe PMC 2933632 PubMed citation Europe PMC 333030 PubMed citation Europe PMC 6210531 PubMed citation Europe PMC 6214725 PubMed citation Europe PMC 6225718 PubMed citation Europe PMC 7243492 PubMed citation Europe PMC 8250149 PubMed citation Europe PMC Last Modified 19 May 2017